Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious […]
Based on preclinical research in cell cultures and animals, a team of investigators at the University of Nottingham in England […]
With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]
Top Doctor at University of Hong Kong Suggests Aggressively Treat COVID-19 Patients Early with Antiviral Cocktail Medications: Hong Kong’s […]
Hong Kong’s medical community knows something about coronaviruses given its experience with the first SARS 17 years ago and of […]
Pfizer has initiated a Phase 1 clinical trial for a novel small molecule called PF-07304814, a compound targeting an enzyme […]
Early in August, TrialSite highlighted that consumer advocacy organizations such as Public Citizen continue to pester federal research agencies to pressure […]
AbbVie (NYSE:ABBV) and Harvard University announced a $30 million collaborative research alliance involving the launch of a multi-prong initiative at […]
South Korea’s Chungnam National University has come together with prominent biotech company Celltrion to launch a Phase 1 clinical trial of a […]
In May, Merck announced a collaboration with Ridgeback Biopharmaceuticals LP (Ridgeback) to jointly develop EIDD-2801, an orally available antiviral candidate […]
